| 前收市價 | 145.79 |
| 開市 | 147.35 |
| 買盤 | 148.48 x 100 |
| 賣出價 | 149.96 x 100 |
| 今日波幅 | 145.98 - 150.27 |
| 52 週波幅 | 143.50 - 218.88 |
| 成交量 | |
| 平均成交量 | 851,009 |
| 市值 | 18.892B |
| Beta 值 (5 年，每月) | 0.40 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -3.51 |
| 業績公佈日 | 2024年5月02日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 222.41 |
ZacksWhy Alnylam Pharmaceuticals (ALNY) Stock Might be a Great Pick
Alnylam Pharmaceuticals (ALNY) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Insider Monkey30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world. If you do not want to learn about the global biotech market, head straight to the 5 Biggest Biotechnology Companies in the World. In the ever-evolving landscape of biotechnology, several companies like Novo Nordisk, Regeneron, and United […]
ZacksAlnylam (ALNY), Roche's Blood Pressure Drug Meets Study Goal
Data from a mid-stage study shows that Alnylam (ALNY) and Roche-partnered zilebesiran, when added to standard-of-care, lowers blood pressure significantly in adults with mild-to-moderate hypertension.
